Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This funding opportunity seeks applications for a Research Coordinating Center (RCC) to support a consortium of clinical centers investigating anti-obesity medication (AOM) treatment strategies in children and adolescents with obesity. The consortium's focus is on identifying optimal approaches regarding the timing of AOM initiation, weight loss parameters, medication class, dosing regimens, and the integration of lifestyle therapies to promote normal development and minimize long-term dependency on these medications. Additionally, research will explore predictors of treatment response to better tailor interventions. The RCC will play a central role in managing and coordinating the consortium's activities, including providing administrative support, leading statistical design and analysis efforts, and harmonizing data collection through standardized protocols and shared laboratory resources. It will also oversee data management, support research collaborations, and facilitate multicenter trials, whether conducted independently or collectively. The initiative is funded by the National Institutes of Health within the Department of Health and Human Services, with key contact provided for further inquiries.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) for a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity to maximize benefits and minimize risks of AOM use. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs. Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation.
The consortium may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts. The RCC will lead, manage, and harmonize efforts for the Consortium including 1) providing management and administrative support; 2) providing leadership and expertise on statistical design and analysis, 3) providing research coordination with a central laboratory, harmonizing data collection methods and common data elements, data management and data analyses for Consortium studies; and 4) fostering research collaborations.
